Percheron Therapeutics (AU:PER) has released an update.
Percheron Therapeutics Limited has announced the quotation of 135,231,746 ordinary fully paid securities on the Australian Securities Exchange, effective October 25, 2024. This move is part of a previously notified transaction and may interest investors keen on burgeoning opportunities within the biotech sector.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
